
Caprolactam Chemicals Faces Intense Selling Pressure Amid Consecutive Gains
2025-12-04 09:50:19Caprolactam Chemicals Ltd has encountered a rare market phenomenon today, with the stock registering a lower circuit and an exclusive queue of sell orders, signalling extreme selling pressure and distress selling. Despite a strong run of consecutive gains over the past eight days, the stock’s current trading session reveals a stark absence of buyers, raising concerns about market sentiment and potential volatility ahead.
Read More
Caprolactam Chemicals Faces Intense Selling Pressure Amid Lower Circuit Lock
2025-12-03 09:55:24Caprolactam Chemicals Ltd witnessed a sharp decline today as the stock hit its lower circuit, marked by an overwhelming presence of sell orders and an absence of buyers. This extreme selling pressure signals distress among investors, with the stock closing down 5.00% against a marginal 0.30% fall in the Sensex, underscoring the severity of the sell-off in the commodity chemicals sector.
Read More
Caprolactam Chemicals Hits New 52-Week High at Rs.69
2025-12-03 09:53:30Caprolactam Chemicals has reached a significant milestone by touching a new 52-week high of Rs.69, marking a notable phase of momentum for the commodity chemicals company. This achievement reflects a sustained upward trend over the past week, underscoring the stock’s strong performance relative to its sector and broader market indices.
Read More
Caprolactam Chemicals Hits New 52-Week High at Rs.66.42
2025-12-02 09:51:41Caprolactam Chemicals has reached a significant milestone by touching a new 52-week high of Rs.66.42, marking a notable phase of momentum in the commodity chemicals sector. This achievement reflects a sustained upward trend over recent sessions, underscoring the stock’s robust performance amid a mixed market backdrop.
Read More
Caprolactam Chemicals Surges with Unprecedented Buying Interest, Hits New 52-Week High
2025-12-02 09:35:24Caprolactam Chemicals has witnessed extraordinary buying momentum, registering a 4.96% gain today and touching a new 52-week high of Rs. 66.42. The stock’s performance starkly contrasts with the broader market, as the Sensex declined by 0.25%, underscoring the robust demand and absence of sellers in the queue.
Read More
Caprolactam Chemicals Surges with Unprecedented Buying Interest, Edging Near 52-Week High
2025-12-01 09:30:21Caprolactam Chemicals Ltd witnessed extraordinary buying momentum today, registering a 5.0% gain and trading exclusively at its intraday high with no sellers in the queue. This remarkable demand has propelled the stock to within 2.67% of its 52-week high, signalling a potential multi-day upper circuit scenario amid sustained investor enthusiasm.
Read MoreIs Caprolactam Chem overvalued or undervalued?
2025-11-29 08:10:58Valuation Metrics Indicate Elevated Pricing Caprolactam Chem’s price-to-earnings (PE) ratio stands at an extraordinary 2771.5, which is significantly higher than typical industry standards. Such an inflated PE ratio suggests that the market is pricing in very high future earnings growth or that current earnings are minimal relative to the share price. The price-to-book (P/B) value of 5.21 further indicates that investors are paying over five times the company’s net asset value, a premium that demands strong justification through operational performance or growth prospects. Other valuation multiples reinforce this expensive stance. The enterprise value to EBIT (EV/EBIT) ratio is 36.68, and the EV to EBITDA ratio is 15.28, both of which are elevated compared to many peer...
Read More
Caprolactam Chemicals Surges with Unprecedented Buying Interest and Upper Circuit Lock
2025-11-28 09:35:24Caprolactam Chemicals has witnessed extraordinary buying momentum, locking in an upper circuit with no sellers in the queue. The stock’s performance today highlights a rare market phenomenon where demand overwhelms supply, signalling potential for a sustained multi-day rally.
Read More
Caprolactam Chemicals Surges with Unprecedented Buying Interest, Eyes Multi-Day Upper Circuit
2025-11-27 09:50:25Caprolactam Chemicals has witnessed extraordinary buying momentum, registering a sharp 4.99% gain today with only buy orders in the queue. This rare market phenomenon signals a potential multi-day upper circuit scenario, reflecting robust investor enthusiasm amid a subdued broader market.
Read MoreBoard Meeting Intimation for Unaudited Financial Results For The Quarter Ended 31St December 2025
27-Jan-2026 | Source : BSECaprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Unaudited financial results for the Quarter ended 31st December 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Jan-2026 | Source : BSECompliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
Closure of Trading Window
30-Dec-2025 | Source : BSEClosure of Trading Window for the quarter ended December 31 2025
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available